Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Operating Expenses (2023 - 2025)

Metagenomi (MGX) has disclosed Operating Expenses for 3 consecutive years, with $28.3 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 6.48% to $28.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $121.2 million through Dec 2025, down 14.15% year-over-year, with the annual reading at $121.2 million for FY2025, 14.15% down from the prior year.
  • Operating Expenses for Q4 2025 was $28.3 million at Metagenomi, down from $31.5 million in the prior quarter.
  • The five-year high for Operating Expenses was $40.2 million in Q1 2024, with the low at $26.6 million in Q1 2023.
  • Average Operating Expenses over 3 years is $32.1 million, with a median of $31.7 million recorded in 2025.
  • The sharpest move saw Operating Expenses soared 51.12% in 2024, then fell 20.51% in 2025.
  • Over 3 years, Operating Expenses stood at $32.6 million in 2023, then decreased by 7.23% to $30.2 million in 2024, then dropped by 6.48% to $28.3 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $28.3 million, $31.5 million, and $29.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.